Connection

Jacqueline Garonzik-Wang to Humans

Back to Details
This is a "connection" page, showing publications Jacqueline Garonzik-Wang has written about Humans.
Jacqueline Garonzik-Wang
Connection Strength
0.190
Humans
  1. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174.
    View in: PubMed
    Score: 0.008
  2. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123.
    View in: PubMed
    Score: 0.008
  3. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83.
    View in: PubMed
    Score: 0.008
  4. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 06 01; 325(21):2204-2206.
    View in: PubMed
    Score: 0.008
  5. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 05 04; 325(17):1784-1786.
    View in: PubMed
    Score: 0.008
  6. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57.
    View in: PubMed
    Score: 0.008
  7. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53.
    View in: PubMed
    Score: 0.008
  8. Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Clin Transplant. 2020 12; 34(12):e14086.
    View in: PubMed
    Score: 0.007
  9. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol. 2021 01; 36(1):143-151.
    View in: PubMed
    Score: 0.007
  10. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020 07; 20(7):1809-1818.
    View in: PubMed
    Score: 0.007
  11. National Variation in Increased Infectious Risk Kidney Offer Acceptance. Transplantation. 2019 10; 103(10):2157-2163.
    View in: PubMed
    Score: 0.007
  12. Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. Transplantation. 2019 06; 103(6):1267-1271.
    View in: PubMed
    Score: 0.007
  13. Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System. Am J Transplant. 2019 11; 19(11):3079-3086.
    View in: PubMed
    Score: 0.007
  14. Complications, length of stay, and cost of cholecystectomy in kidney transplant recipients. Am J Surg. 2018 10; 216(4):694-698.
    View in: PubMed
    Score: 0.006
  15. Outcomes Following Colorectal Resection in Kidney Transplant Recipients. J Gastrointest Surg. 2018 09; 22(9):1603-1610.
    View in: PubMed
    Score: 0.006
  16. Surgical approach, cost, and complications of appendectomy in kidney transplant recipients. Clin Transplant. 2018 05; 32(5):e13245.
    View in: PubMed
    Score: 0.006
  17. Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States. Transplantation. 2018 04; 102(4):609-615.
    View in: PubMed
    Score: 0.006
  18. Application and interpretation of histocompatibility data in liver transplantation. Curr Opin Organ Transplant. 2017 Oct; 22(5):499-504.
    View in: PubMed
    Score: 0.006
  19. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination. Arthritis Rheumatol. 2022 01; 74(1):28-32.
    View in: PubMed
    Score: 0.002
  20. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281.
    View in: PubMed
    Score: 0.002
  21. Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV. AIDS. 2021 11 15; 35(14):2399-2401.
    View in: PubMed
    Score: 0.002
  22. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271.
    View in: PubMed
    Score: 0.002
  23. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
    View in: PubMed
    Score: 0.002
  24. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856.
    View in: PubMed
    Score: 0.002
  25. Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV. AIDS. 2021 09 01; 35(11):1872-1874.
    View in: PubMed
    Score: 0.002
  26. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366.
    View in: PubMed
    Score: 0.002
  27. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588.
    View in: PubMed
    Score: 0.002
  28. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332.
    View in: PubMed
    Score: 0.002
  29. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series. Ann Intern Med. 2021 09; 174(9):1332-1334.
    View in: PubMed
    Score: 0.002
  30. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1351-1352.
    View in: PubMed
    Score: 0.002
  31. Response to "COVID-19 in SOT versus non-SOT". Am J Transplant. 2021 06; 21(6):2306.
    View in: PubMed
    Score: 0.002
  32. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021 07; 21(7):2498-2508.
    View in: PubMed
    Score: 0.002
  33. Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 2021 01 01; 105(1):216-224.
    View in: PubMed
    Score: 0.002
  34. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant. 2021 05; 21(5):1838-1847.
    View in: PubMed
    Score: 0.002
  35. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020 11; 20(11):3131-3139.
    View in: PubMed
    Score: 0.002
  36. Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study. Am J Transplant. 2020 11; 20(11):2997-3007.
    View in: PubMed
    Score: 0.002
  37. Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study. Nephrol Dial Transplant. 2020 07 01; 35(7):1262-1270.
    View in: PubMed
    Score: 0.002
  38. Dynamic Frailty Before Kidney Transplantation: Time of Measurement Matters. Transplantation. 2019 08; 103(8):1700-1704.
    View in: PubMed
    Score: 0.002
  39. Reclaiming missed opportunities: a strategy of targeted direct-acting antiviral prophylaxis for HCV-seronegative recipients of HCV-seropositive donor kidneys. Transpl Int. 2019 07; 32(7):690-692.
    View in: PubMed
    Score: 0.002
  40. Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers. Clin Transplant. 2019 08; 33(8):e13637.
    View in: PubMed
    Score: 0.002
  41. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study. Transplantation. 2019 06; 103(6):1216-1223.
    View in: PubMed
    Score: 0.002
  42. Accelerating kidney allocation: Simultaneously expiring offers. Am J Transplant. 2019 11; 19(11):3071-3078.
    View in: PubMed
    Score: 0.002
  43. Temporal trends and hospital costs associated with an endovascular-first approach for acute limb ischemia. J Vasc Surg. 2019 11; 70(5):1506-1513.e1.
    View in: PubMed
    Score: 0.002
  44. Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas. Ann Hepatol. 2018 Nov - Dec; 17(6):1052-1066.
    View in: PubMed
    Score: 0.002
  45. National Trends in Liver Transplantation in Older Adults. J Am Geriatr Soc. 2018 12; 66(12):2321-2326.
    View in: PubMed
    Score: 0.002
  46. Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients With End-stage Renal Disease in a Prospective Cohort Study. Transplantation. 2018 10; 102(10):1740-1746.
    View in: PubMed
    Score: 0.002
  47. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study. Transplantation. 2018 09; 102(9):1514-1519.
    View in: PubMed
    Score: 0.002
  48. Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study. Transplantation. 2018 07; 102(7):1148-1155.
    View in: PubMed
    Score: 0.002
  49. Reported effects of the Scientific Registry of Transplant Recipients 5-tier rating system on US transplant centers: results of a national survey. Transpl Int. 2018 10; 31(10):1135-1143.
    View in: PubMed
    Score: 0.002
  50. Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation. 2018 03; 102(3):471-477.
    View in: PubMed
    Score: 0.002
  51. MELD as a metric for survival benefit of liver transplantation. Am J Transplant. 2018 05; 18(5):1231-1237.
    View in: PubMed
    Score: 0.002
  52. Liver Transplantation for Severe Alcoholic Hepatitis, Updated Lessons from the World's Largest Series. J Am Coll Surg. 2018 04; 226(4):549-557.
    View in: PubMed
    Score: 0.002
  53. Frailty and Postkidney Transplant Health-Related Quality of Life. Transplantation. 2018 02; 102(2):291-299.
    View in: PubMed
    Score: 0.002
  54. Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys. Am J Transplant. 2018 03; 18(3):617-624.
    View in: PubMed
    Score: 0.001
  55. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. Am J Transplant. 2018 03; 18(3):650-658.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.